Benova Healthcare UK Limited iXBRL

Company Registration Number: 12198818

Benova Healthcare UK Limited

Directors' Report and Unaudited Financial Statements

for the financial year ended 31 December 2024

Benova Healthcare UK Limited

DIRECTORS AND OTHER INFORMATION


Directors	Mark Rudolf Steinmann
	Margaret Norma Jackson


Company Secretary	Margaret Norma Jackson


Company Registration Number	12198818


Business Address	Bridge House
	Wentbridge
	Pontefract
	WF8 3JJ


Accountants	FLC Frank Lynch & Co
	Chartered Cerified Accountants
	'Avoca House'
	28-31 Seatown Place
	Dundalk
	Co. Louth
	Republic of Ireland

Benova Healthcare UK Limited

DIRECTORS' REPORT

for the financial year ended 31 December 2024

The directors present their report and the unaudited financial statements for the financial year ended 31 December 2024.

Directors

The directors who served during the financial year are as follows:

Mark Rudolf Steinmann

Margaret Norma Jackson

There were no changes in shareholdings between 31 December 2024 and the date of signing the financial statements.

In accordance with the Constitution, the directors retire by rotation and, being eligible, offer themselves for re-election.

Political Contributions

The company did not make any disclosable political donations in the current financial year.

Statement of Directors' Responsibilities

The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A (Small Entities). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Special provisions relating to small companies

The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

On behalf of the board

___________________________

Mark Rudolf Steinmann

Margaret Norma Jackson

Director

25 September 2025

Benova Healthcare UK Limited

CHARTERED CERIFIED ACCOUNTANTS REPORT

to the Board of Directors on the Compilation of the unaudited financial statements of Benova Healthcare UK Limited

for the financial year ended 31 December 2024

In accordance with our engagement letter dated 25 September 2025 and in order to assist you to fulfil your duties under the Companies Act 2006, we have compiled for your approval the financial statements of the company for the financial year ended 31 December 2024 as set out on pages 6 to 12 which comprise the Profit and Loss Account, the Balance Sheet, the Reconciliation of Shareholders' Funds and the related notes from the company's accounting records and from information and explanations you have given to us.

This report is made solely to the Board of Directors of Benova Healthcare UK Limited, as a body, in accordance with the terms of our engagement. Our work has been undertaken so that we might compile the financial statements that we have been engaged to compile, report to the company’s Board of Directors that we have done so, and state those matters that we have agreed to state to them in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and its Board of Directors, as a body, for our work or for this report.

As a firm regulated by the Association of Chartered Certified Accountants our work will be carried out in accordance with the Technical Factsheet 163 Audit Exempt Companies - ACCA Accounts Preparation Report and ISRS 4410 International Standard on Related Services -Compilation Engagements. ln carrying out this engagement we have complied with the ethical guidance laid down by the association relating to members undertaking the compilation of financial statements.

Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at
<http://www.accaglobal.com/ie/en/technical-activities/technical-resources-search/2009/october/factsheet-163-audit-exempt-companies.html>

You have acknowledged on the Balance Sheet for the year ended 31 December 2024 your duty to ensure that Benova Healthcare UK Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Benova Healthcare UK Limited. You consider that Benova Healthcare UK Limited is exempt from the statutory audit requirement for the financial year.

We have not been instructed to carry out an audit or a review of the financial statements of Benova Healthcare UK Limited. For this reason, we have not verified the adequacy, accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

__________________________________

FLC FRANK LYNCH & CO

Chartered Cerified Accountants

'Avoca House'

28-31 Seatown Place

Dundalk

Co. Louth

Republic of Ireland

25 September 2025

Benova Healthcare UK Limited

PROFIT AND LOSS ACCOUNT

for the financial year ended 31 December 2024

	2024	2023
Notes	£	£

Turnover	3,839,321	1,640,324

Cost of sales	(3,685,741)	(1,525,264)
	─────────	─────────
Gross profit	153,580	115,060

Administrative expenses	(131,756)	(56,220)
	─────────	─────────
Profit before taxation	21,824	58,840

Tax on profit	(4,269)	(12,906)
	─────────	─────────
Profit for the financial year	17,555	45,934
	─────────	─────────
Total comprehensive income	17,555	45,934
	═════════	═════════

Benova Healthcare UK Limited

Company Registration Number: 12198818

BALANCE SHEET

as at 31 December 2024

		2024	2023
	Notes	£	£

Fixed Assets

Tangible assets

1,271

1,293

─────────

Current Assets

Stocks

910,624

165,482

Debtors

962,483

595,938

Cash and cash equivalents

394,165

89,354

─────────

2,267,272

850,774

─────────

Creditors: amounts falling due within one year

(2,194,939)

(796,018)

─────────

Net Current Assets

72,333

54,756

─────────

Total Assets less Current Liabilities

73,604

56,049

═════════

Capital and Reserves

Called up share capital

Retained earnings

73,602

56,047

─────────

Shareholders' Funds

73,604

56,049

═════════

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Board and authorised for issue on 25 September 2025 and signed on its behalf by



________________________________			________________________________
Mark Rudolf Steinmann			Margaret Norma Jackson
Director			Director

Benova Healthcare UK Limited

RECONCILIATION OF SHAREHOLDERS' FUNDS

as at 31 December 2024

	Called up	Retained	Total
	share	earnings
	capital
	£	£	£

At 1 January 2023	2	10,113	10,115
	─────────	─────────	─────────
Profit for the financial year	-	45,934	45,934
	─────────	─────────	─────────
At 31 December 2023	2	56,047	56,049
	─────────	─────────	─────────
Profit for the financial year	-	17,555	17,555
	─────────	─────────	─────────
At 31 December 2024	2	73,602	73,604
	═════════	═════════	═════════

Benova Healthcare UK Limited

NOTES TO THE FINANCIAL STATEMENTS

for the financial year ended 31 December 2024

General Information

Benova Healthcare UK Limited is a company limited by shares incorporated and registered in England. The registered number of the company is 12198818. The registered office of the company is. The principal activity of the company is the sale of nutritional and sports supplements. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

Summary of Significant Accounting Policies

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.

Statement of compliance

The financial statements of the company for the financial year ended 31 December 2024 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.

Turnover

Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.

Tangible assets and depreciation

Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:

Fixtures, fittings and equipment

15% Straight line

The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.

Stocks

Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition. Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Taxation and deferred taxation

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.

Ordinary share capital

The ordinary share capital of the company is presented as equity.

Employees

The average monthly number of employees, including directors, during the financial year was 2, (2023 - 2).

2024

2023

Number

Number

Directors

═════════


4.	Tangible assets
		Fixtures,	Total
		fittings and
		equipment
		£	£
	Cost
	At 1 January 2024	2,608	2,608
	Additions	624	624
		─────────	─────────
	At 31 December 2024	3,232	3,232
		─────────	─────────
	Depreciation
	At 1 January 2024	1,315	1,315
	Charge for the financial year	646	646
		─────────	─────────
	At 31 December 2024	1,961	1,961
		─────────	─────────
	Net book value
	At 31 December 2024	1,271	1,271
		═════════	═════════
	At 31 December 2023	1,293	1,293
		═════════	═════════


5.	Stocks	2024	2023
		£	£

	Finished goods and goods for resale	910,624	165,482
		═════════	═════════

	The replacement cost of stock did not differ significantly from the figures shown.


6.	Debtors	2024	2023
		£	£

	Trade debtors	811,651	509,330
	Other debtors	21,854	21,854
	Directors' current accounts	64,754	64,754
	Prepayments and accrued income	64,224	-
		─────────	─────────
		962,483	595,938
		═════════	═════════


7.	Creditors	2024	2023
	Amounts falling due within one year	£	£

	Trade creditors	1,656,546	488,762
	Amounts owed to connected parties (Note 10)	41,362	76,833
	Taxation (Note 8)	486,031	222,423
	Accruals	11,000	8,000
		─────────	─────────
		2,194,939	796,018
		═════════	═════════


8.	Taxation	2024	2023
		£	£

	Creditors:
	VAT	482,242	187,663
	Corporation tax	3,789	34,760
		─────────	─────────
		486,031	222,423
		═════════	═════════

Capital commitments

The company had no material capital commitments at the financial year-ended 31 December 2024.


10.	Related party transactions

	The following amounts are due to other connected parties:
		2024	2023
		£	£

	Benova Healthcare Ireland Limited	41,362	76,833
		═════════	═════════

11.

Post-Balance Sheet Events

There have been no significant events affecting the company since the financial year-end.